Correlation between the presence of antibodies to native DNA and the occurrence of the LE phenomenon in patients with visceral lupus erythematosus
Marczak, M.; Kardaszewicz, E.; Sikora, M.
Polski Tygodnik Lekarski 37(12): 339-340
1982
ISSN/ISBN: 0032-3756 PMID: 6182556 Document Number: 192099
Document emailed within 1 workday
Related Documents
Ohe, A.; Koda, S.; Negoro, N.; Okamura, M.; Amatsu, K.; Kohno, M.; Kanayama, Y.; Inoue, T.; Takeda, T. 1982: A case of hydralazine-induced lupus erythematosus with circulating antibodies to native DNA Osaka City Medical Journal 28(2): 149-151Dixon, J.A.; Mulhern, L.M.; Whiteside, T.L.; Luksick, J. 1980: Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus Journal of Rheumatology 7(4): 544-546
Maradona Hidalgo, J.A.; Alvarez Alvarez, C.; Asensi Alvarez, V.; Diéguez Junquera, M.A. 1985: Systemic lupus erythematosus and anti-native-DNA antibodies measured using Crithidia luciliae Medicina Clinica 84(10): 416-417
Kostadinova, D.A.; Razboĭnikov, S. 1976: Antibodies against native DNA. the methods for their demonstration. their diagnostic and pathogenetic importance in systemic lupus erythematosus Vutreshni Bolesti 15(2): 18-26
Osnos, M.C.; Eyquem, A. 1979: Systemic lupus erythematosus and anti-native desoxyribonucleic acid antibodies: clinical and laboratory comparison of the results given by two methods of detection La Nouvelle Presse Medicale 8(30): 2451-2456
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Lolli, C.; Foscoli, M.; Giofrè, R.; Tarquinii, M.; Pasquali, S.; Toschi, G.P. 1993: Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies Giornale Italiano di Cardiologia 23(11): 1125-1134
Asherson, R.A.; Gómez-Puerta, J.A.; Marinopoulos, G. 2005: Recurrent pulmonary thromboembolism in a patient with systemic lupus erythematosus and HIV-1 infection associated with the presence of antibodies to prothrombin: a case report Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(10): E89-E92
Beenken, O.; Häntzschel, H.; Birkenmeier, G.; Pietruschka, W.D.; Otto, W. 1976: Protein-analytical studies on the serum and urine of patients with visceral lupus erythematosus Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(6): 180-182
Manent-Ducreuzet, C.; Margulis, J.; Kahn, M.F. 1981: Comparison of severity and native anti-DNA antibody levels in systemic lupus erythematosus. Serodiscordant lupus Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(11): 705-712
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Vandersteen, P.R.; Jordon, R.E. 1974: Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus Archives of Dermatology 110(1): 95-98
Asherson, R.A.; Thompson, R.P.; MacLachlan, N.; Baguley, E.; Hicks, P.; Hughes, G.R. 1989: Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus Journal of Rheumatology 16(2): 219-224
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Cherniak, V.I.; Savel'ev, A.I.; Mikhailova, V.S. 1975: Reaction of peripheral blood leukocyte migration inhibition in the presence of DNA in patients with systemic lupus erythematosus Klinicheskaia Meditsina 53(11): 97-102
Leaños Miranda, L.; Bustos López, H.H.; Fraga Mouret, A.; Blanco Favela, F.; Dalila Pascoe Lira, M.E.; Dalila Pascoe Lira, C. 1998: Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia Ginecologia y Obstetricia de Mexico 66: 179-186
Alarcon-Segovia, D.; Mestanza, M.; Cabiedes, J.; Cabral, A.R. 1997: The antiphospholipid/cofactor syndromes. II. a variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein i but no antibodies detectable in standard antiphospholipid assays Journal of Rheumatology 24(8): 1545-1551
Apostoloff, E.; Hengst, P.; Jendrusch, C.; Apostoloff, G. 1971: Visceral lupus erythematosus and pregnancy Das Deutsche Gesundheitswesen 26(45): 2135-2139
Levy, R.A.; Gharavi, A.E.; Sammaritano, L.R.; Habina, L.; Qamar, T.; Lockshin, M.D. 1990: Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis Journal of Rheumatology 17(8): 1036-1041
Falcao, C.A.; Alves, I.C.; Chahade, W.H.; Duarte, A.L.B.P.; Lucena-Silva, N. 2002: Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus Arquivos Brasileiros de Cardiologia 79(3): 285-291